Sarcomas are frequent tumors in children and young adults that, despite a relative chemo-sensitivity, show high relapse rates with up to 80% of metastatic patients dying in 5 years from diagnosis. The real ontogeny of sarcomas is still debated and evidences suggest they may derive from precursors identified within mesenchymal stromal/stem cells (MSC) fractions. Recent studies on sarcoma microenvironment additionally indicated that MSC could take active part in generation of a supportive stroma. Based on this knowledge, we conceived to use modified MSC to deliver tumor necrosis factor related apoptosis inducing ligand (TRAIL) targeting different sarcoma histotypes. Gene modified MSC expressing TRAIL were co-cultured with different osteosarcoma, rhabdomyosarcoma and Ewing's Sarcoma (ES) cell lines assessing viability and caspase-8 activation. An in vivo model focused on ES was then implemented considering the impact of MSC-TRAIL on tumor size, apoptosis and angiogenesis. MSC expressing TRAIL induced significantly high apoptosis in all tested lines. Sarcoma death was specifically associated with caspase-8 activation starting from 8 hours of co-culture with MSC-TRAIL. When injected into pre-established ES xenotransplants, MSC-TRAIL persisted within its stroma, causing significant tumor apoptosis versus control groups. Additional histological and in vitro studies reveal that MSC-TRAIL could also exert potent anti-angiogenic functions. Our results suggest that MSC as TRAIL vehicles could open novel therapeutic opportunities for sarcoma by multiple mechanisms.

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas / Grisendi, Giulia; Spano, Maria Carlotta; D'Souza, Naomi; Rasini, Valeria; Veronesi, Elena; Prapa, Malvina; Petrachi, Tiziana; Piccinno, MARIA SERENA; Rossignoli, Filippo; Burns, Jorge Phillip Joaquin Sans; Fiorcari, Stefania; Granchi, Donatella; Baldini, Nicola; Horwitz, EDWIN MARK; Guarneri, Valentina; Conte, Pierfranco; Paolucci, Paolo; Dominici, Massimo. - In: STEM CELLS. - ISSN 1066-5099. - STAMPA. - 33:3(2015), pp. 859-869. [10.1002/stem.1903]

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas

GRISENDI, Giulia;SPANO, Maria Carlotta;RASINI, Valeria;VERONESI, Elena;PRAPA, MALVINA;PETRACHI, TIZIANA;PICCINNO, MARIA SERENA;ROSSIGNOLI, FILIPPO;BURNS, Jorge Phillip Joaquin Sans;FIORCARI, STEFANIA;HORWITZ, EDWIN MARK;GUARNERI, Valentina;CONTE, Pierfranco;PAOLUCCI, Paolo;DOMINICI, Massimo
2015

Abstract

Sarcomas are frequent tumors in children and young adults that, despite a relative chemo-sensitivity, show high relapse rates with up to 80% of metastatic patients dying in 5 years from diagnosis. The real ontogeny of sarcomas is still debated and evidences suggest they may derive from precursors identified within mesenchymal stromal/stem cells (MSC) fractions. Recent studies on sarcoma microenvironment additionally indicated that MSC could take active part in generation of a supportive stroma. Based on this knowledge, we conceived to use modified MSC to deliver tumor necrosis factor related apoptosis inducing ligand (TRAIL) targeting different sarcoma histotypes. Gene modified MSC expressing TRAIL were co-cultured with different osteosarcoma, rhabdomyosarcoma and Ewing's Sarcoma (ES) cell lines assessing viability and caspase-8 activation. An in vivo model focused on ES was then implemented considering the impact of MSC-TRAIL on tumor size, apoptosis and angiogenesis. MSC expressing TRAIL induced significantly high apoptosis in all tested lines. Sarcoma death was specifically associated with caspase-8 activation starting from 8 hours of co-culture with MSC-TRAIL. When injected into pre-established ES xenotransplants, MSC-TRAIL persisted within its stroma, causing significant tumor apoptosis versus control groups. Additional histological and in vitro studies reveal that MSC-TRAIL could also exert potent anti-angiogenic functions. Our results suggest that MSC as TRAIL vehicles could open novel therapeutic opportunities for sarcoma by multiple mechanisms.
17-feb-2015
33
3
859
869
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas / Grisendi, Giulia; Spano, Maria Carlotta; D'Souza, Naomi; Rasini, Valeria; Veronesi, Elena; Prapa, Malvina; Petrachi, Tiziana; Piccinno, MARIA SERENA; Rossignoli, Filippo; Burns, Jorge Phillip Joaquin Sans; Fiorcari, Stefania; Granchi, Donatella; Baldini, Nicola; Horwitz, EDWIN MARK; Guarneri, Valentina; Conte, Pierfranco; Paolucci, Paolo; Dominici, Massimo. - In: STEM CELLS. - ISSN 1066-5099. - STAMPA. - 33:3(2015), pp. 859-869. [10.1002/stem.1903]
Grisendi, Giulia; Spano, Maria Carlotta; D'Souza, Naomi; Rasini, Valeria; Veronesi, Elena; Prapa, Malvina; Petrachi, Tiziana; Piccinno, MARIA SERENA; Rossignoli, Filippo; Burns, Jorge Phillip Joaquin Sans; Fiorcari, Stefania; Granchi, Donatella; Baldini, Nicola; Horwitz, EDWIN MARK; Guarneri, Valentina; Conte, Pierfranco; Paolucci, Paolo; Dominici, Massimo
File in questo prodotto:
File Dimensione Formato  
Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 1.07 MB
Formato Adobe PDF
1.07 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1117837
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 35
social impact